ImpediMed Limited
ImpediMed Limited
Your view on IPD.AX
Overview
What the company does, where it operates, and who runs it.
About ImpediMed Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Erik Anderson
- Headquarters
- 5900 Pasteur Court, Carlsbad, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Erik Anderson
- Headquarters
- 5900 Pasteur Court, Carlsbad, CA, US
Operating as a medical software technology provider, ImpediMed Limited is responsible for the development, production, and global sales of bioimpedance spectroscopy (BIS) instruments and accompanying software solutions, serving markets in Australia, North America, and internationally.
Its product portfolio features SOZO, a non-invasive BIS device used for evaluating lymphedema and tracking fluid levels in heart failure patients.
Additionally, it offers the SFB7, a single-channel, tetrapolar BIS instrument for analyzing body composition in healthy individuals, and ImpediVET, another single-channel, tetrapolar BIS device specifically designed for veterinary applications to measure fluid status and tissue composition.
ImpediMed primarily sells its technology to hospitals and clinics. This Australian-headquartered firm, based in Pinkenba, was established in 1999.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for ImpediMed Limited. Starting points for ImpediMed Limited: EPS -AUD 0.01, beta 1.09 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for ImpediMed Limited. ImpediMed Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for ImpediMed Limited. Trailing twelve-month EPS for ImpediMed Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrJun 2018 | Next QtrJun 2022 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | −AUD 0.07 | −AUD 0.01 | −AUD 0.00 | −AUD 0.00 |
| Low estimate | −AUD 0.07 | −AUD 0.01 | −AUD 0.00 | −AUD 0.00 |
| High estimate | −AUD 0.07 | −AUD 0.01 | −AUD 0.00 | −AUD 0.00 |
| No. of analysts | 4 | 4 | 2 | 3 |
| Year-ago EPS | — | — | −AUD 0.011 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrJun 2018 | Next QtrJun 2022 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | AUD 6.09M | AUD 22.50M | AUD 19.20M | AUD 25.18M |
| Low estimate | AUD 4.75M | AUD 18.33M | AUD 18.75M | AUD 23.73M |
| High estimate | AUD 7.24M | AUD 27.95M | AUD 19.64M | AUD 26.64M |
| No. of analysts | 4 | 4 | 1 | 2 |
| Year-ago revenue | — | — | AUD 14.61M | — |
| Growth | — | — | +31.4% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for ImpediMed Limited. ImpediMed Limited has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ATX.AXAmplia Therapeutics Limited | Healthcare | Biotechnology | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| CYC.AXCyclopharm Limited | Healthcare | Medical - Devices | — | ||
| EYE.AXNova Eye Medical Limited | Healthcare | Medical - Devices | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| M7T.AXMach7 Technologies Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| MVP.AXMedical Developments International Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| MX1.AXMicro-X Limited | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BIOBio-Rad Laboratories, Inc. | Healthcare | NYSE | $10.0B | ||
| BIO-BBio-Rad Laboratories, Inc. | Healthcare | NYSE | $9.6B | ||
| BJDXBluejay Diagnostics, Inc. | Healthcare | NASDAQ | $2.0M | ||
| BMRABiomerica, Inc. | Healthcare | NASDAQ | $5.0M | ||
| BRKRBruker Corporation | Healthcare | NASDAQ | $9.7B | ||
| BRKRPBruker Corporation | Healthcare | NASDAQ | $9.6B | ||
| BRNHFBroncus Holding Corporation | Healthcare | OTC | $42.1M | ||
| BRSFBrain Scientific Inc. | Healthcare | OTC | $124 | ||
| BSXBoston Scientific Corporation | Healthcare | NYSE | $63.3B | ||
| BTCYBiotricity, Inc. | Healthcare | OTC | $7.7M | ||
| BVSBioventus Inc. | Healthcare | NASDAQ | $727.2M | ||
| CALZFPolyNovo Limited | Healthcare | OTC | $472.9M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold ImpediMed Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for ImpediMed Limited. Coverage tracks ImpediMed Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of ImpediMed Limited.